Upcoming events

Factors that impact on response to antiplatelet treatment

Session comprising selected EuroPCR 2014 abstract submissions

Chairpersons: G. Cayla, J.P. Collet

Presentations available when logged in:

  • Increased mean platelet volume is associated with non-responsiveness to clopidogrel
  • Impact of obesity and the metabolic syndrome on response to Clopidogrel or Prasugrel and bleeding risk in patients treated after coronary stenting
  • Morphine is associated with a delayed activity of oral antiplatelet agents in patients with STEMI undergoing primary PCI
  • Safety of protamine sulphate administration following PCI
  • Perioperative cardiac risk following minor surgery under discontinuation of all antiplatelet therapy in patients with prior DES implantation